Finance

Lists
RKV:CVE
Rakovina Therapeutics Inc
CA$0.13
+8.33%
(+0.0100) 1D
Aug 7, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RKV...
Open
CA$0.13
High
CA$0.13
Low
CA$0.13
Mkt. cap
3.17M
Avg. vol.
0.00
Volume
42.00K
52-wk high
CA$0.60
52-wk low
CA$0.08
EPS
-CA$0.43
Beta
0.44
Shares outstanding
24.41M
Open
CA$0.13
High
CA$0.13
Low
CA$0.13
Mkt. cap
3.17M
Avg. vol.
0.00
Volume
42.00K
52-wk high
CA$0.60
52-wk low
CA$0.08
EPS
-CA$0.43
Beta
0.44
Shares outstanding
24.41M
About Rakovina Therapeutics Inc
CEO-
Employees-
Founded2019
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.61M
1.10M
828.93K
1.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.21M
539.17K
972.87K
443.99K
Operating expense
2.83M
1.64M
1.80M
1.48M
Total operating expenses
2.83M
1.64M
1.80M
1.48M
Operating income
-2.83M
-1.64M
-1.80M
-1.48M
Other non operating income
-
-
1.00
-
EBT including unusual items
-2.92M
-1.78M
-1.89M
-1.68M
EBT excluding unusual items
-2.92M
-1.78M
-1.91M
-1.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.92M
-1.78M
-1.89M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
773.00
-
Interest expense
-91.69K
-139.75K
-108.48K
-101.81K
Net interest expenses
-91.69K
-139.75K
-107.70K
-101.81K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.69M
-1.51M
-1.67M
-1.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps